FIGURE

Fig. 6

ID

ZDB-FIG-190529-12

Publication

Abou-Saleh et al., 2019 - Impaired Liver Size and Compromised Neurobehavioral Activity are Elicited by Chitosan Nanoparticles in the Zebrafish Embryo Model

Other Figures

All Figure Page

Back to All Figure Page

Fig. 6

(A) Representative images for the RFP liver area after each treatment. (B) Quantification and measurement of the RFP liver area (mm²) for the controls and all the tested compounds. (C) Representative images for steatosis and yolk retention. Arrow (↗) in EtOH treatment indicate liver steatosis (absorbed ORO stain by the liver), and arrows (↗) in paracetamol (APAP) and ChNP treatments indicate increased yolk retention (absorbed ORO stain by the yolk). (D) Percentages of embryos showed yolk retention and (E) steatosis. Thirty embryos were used for each treatment in every experiment. *, significantly different from DMSO (p < 0.05); **, significantly different from DMSO (p < 0.01).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Nanomaterials (Basel)